Qiagen (QGEN) EBIT (2009 - 2025)

Qiagen has disclosed EBIT across 17 years of filings, most recently posting $99.4 million for Q4 2025.

• EBIT for Q4 2025 came in at $99.4 million, down 16.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $465.9 million (up 376.76% YoY), and the FY2025 annual result was $465.9 million, up 376.76% from the prior year.
• EBIT came in at $99.4 million for Q4 2025 at Qiagen, down from $129.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $207.1 million in Q1 2022 to a low of -$228.4 million in Q2 2024.
• The 5-year median for EBIT is $112.1 million (2024), against an average of $105.4 million.
• Across the five-year window, EBIT slumped 316.67% in 2024 and soared 153.36% in 2025, its largest moves.
• Qiagen's EBIT stood at $173.1 million in 2021, then plunged by 39.6% to $104.6 million in 2022, then grew by 5.78% to $110.6 million in 2023, then gained by 7.67% to $119.1 million in 2024, then dropped by 16.51% to $99.4 million in 2025.
• The last three EBIT figures came in at $99.4 million (Q4 2025), $129.2 million (Q3 2025), and $121.9 million (Q2 2025), per Business Quant data.